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Cerebellar granule cell precursors (GCPs) proliferate in the outer part of the external 
granular layer (EGL). They begin their differentiation by exiting the cell cycle and 
migrating into the inner part of the EGL. Here we report that JSAP1, a scaffold protein for 
JNK signaling pathways, is expressed predominantly in the post-mitotic GCPs of the inner 
EGL. JSAP1 knockdown or treatment with a JNK inhibitor enhances the proliferation of 
cultured GCPs, but the overexpression of wild-type JSAP1 leads to increased proportions 
of p27Kip1- and NeuN-positive cells, even with saturating concentrations of Sonic 
hedgehog (Shh), a potent GCP mitogen. However, these differentiation-promoting effects 
on GCPs are attenuated significantly in cells overexpressing a mutant JSAP1 that lacks the 
JNK-binding domain. Together, these data suggest that JSAP1 antagonizes the mitogenic 
effect of Shh on GCPs and promotes their exit from the cell cycle and differentiation, by 





 Cerebellar granule cells, which are by far the most abundant neurons in the central 
nervous system, arise from a germinal zone in the rhombic lip. The granule cell precursors 
(GCPs) leave the rhombic lip and migrate tangentially to form a secondary germinal zone, 
called the external granular layer (EGL). In rodents, GCPs in the outer part of the EGL 
proliferate extensively for 2-3 weeks after birth, thus greatly expanding their population. 
GCPs start differentiating by exiting the cell cycle and moving into the inner part of the 
EGL. They then migrate further and radially past the Purkinje cells to their final 
destination, the internal granular layer (IGL) (Hatten, 1999). 
 Previous studies have indicated that multiple molecules act as mitogenic factors for 
GCPs, of which sonic hedgehog (Shh) is likely to be the most potent (Dahmane and Ruiz i 
Altaba, 1999; Wallace, 1999; Wechsler-Reya and Scott, 1999). On the other hand, 
Miyazawa et al. (2000) demonstrated that p27Kip1, a cyclin-dependent kinase (CDK) 
inhibitor, is involved in terminating the division of GCPs and permitting their 
differentiation. Furthermore, basic fibroblast growth factor (bFGF) has been reported to 
block Shh signaling in GCPs and to promote their differentiation by modulating c-Jun 
NH2-terminal kinase (JNK) activity (Wechsler-Reya and Scott, 1999; Fogarty et al., 2007). 
Together, these studies have shed considerable light on the molecules involved in 
determining the fate of GCPs, in terms of their decision to continue or stop dividing. 
However, it is largely unknown how intracellular signaling pathways are activated 
specifically and efficiently to exert the relevant cell-fate specification of GCPs. 
 Mammalian mitogen-activated protein kinase (MAPK) intracellular signaling 
pathways play key roles in multiple cellular processes, including proliferation and 
differentiation (Kyriakis and Avruch, 2001; Chang and Karin, 2001). Scaffold proteins for 
MAPK pathways are thought to function in the spatial and temporal regulation of these 
pathways by organizing the MAPK signaling components into functional modules 
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(Morrison and Davis, 2003; Yoshioka, 2004; Dhanasekaran, et al. 2007). These scaffolding 
complexes enable the efficient activation of specific MAPK cascades. We previously 
identified JNK/stress-activated protein kinase-associated protein 1 (JSAP1, also known as 
JNK-interacting protein 3 (JIP3)) as a scaffold protein for mammalian JNK MAPK 
pathways (Ito et al., 1999, 2000; Kelkar et al., 2000). In the developing mouse brain, 
JSAP1 is highly expressed in progenitor cells, including the GCPs of the cerebellar EGL 
(Miura et al., 2006). In the present study, we analyzed the expression of JSAP1 and JNK 
in the developing mouse cerebellum by immunohistochemistry. We also studied the 
proliferation and differentiation of cultured GCPs in which we knocked down the RNA for 
JSAP1 or forced the expression of either wild-type JSAP1 or a mutant JSAP1 lacking its 
JNK-binding domain (JBD), in the presence or absence of Shh. Our results strongly 







Expression of JSAP1 and JNK in the developing cerebellum 
 
 To determine if JSAP1 could play a role in GCP fate decisions, we first examined the 
expression of JSAP1 and JNK in the developing mouse cerebellum by 
immunohistochemistry (Fig. 1, Fig. 2, Supplementary Fig. 1). We double-labeled frozen 
sections of postnatal day 6 (P6) mouse cerebella with antibodies against JSAP1, JNK, 
phosphorylated (activated) JNK (P-JNK), Ki67 (a proliferation marker), p27Kip1 (a 
negative regulator of the GCP cell cycle; Miyazawa et al., 2000), NeuN (a neural 
differentiation marker), and calbindin (a Purkinje cell marker), focusing on their 
expression patterns in the EGL. The double-labeled proteins with JSAP1 were Ki67, 
p27Kip1, NeuN (Fig. 1), JNK, P-JNK (Fig. 2), and calbindin (Supplementary Fig. 1). In 
addition, the double immunostaining for P-JNK and calbindin was performed 
(Supplementary Fig. 1). For these double staining experiments, two types of antibodies 
against P-JNK, i.e. monoclonal and polyclonal antibodies, were used: the former in Fig. 2 
and the later in Supplementary Fig. 1, respectively. The specificity of both antibodies was 
confirmed by immunoblotting, in which mouse embryonic fibroblasts (MEFs) were 
stimulated to activate JNK, and the cell lyates were untreated or treated with bacterial 
alkaline phosphatase (BAP) prior to immunoblotting (data not shown). Ki67, NeuN, and 
p27Kip1 are known nuclear proteins; JSAP1, JNK, and P-JNK were, by contrast, expressed 
exclusively in the cytoplasm.  
As expected, the outer EGL was positive for the proliferating cell marker Ki67, and 
the inner EGL was positive for p27Kip1 and NeuN (Figs. 1B, E, H). Labeling for JSAP1 
was low to moderate in the outer EGL and intense in the inner EGL. The 
immunofluorescent signals for JNK showed a very similar pattern and mostly overlapped 
with the JSAP1 labeling (Figs. 2C, G). There was little immunoreactivity for P-JNK in the 
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outer EGL or in the most superficial portion of the inner EGL, but P-JNK staining was 
intense in the lower portion of the inner EGL (Figs. 2M, O). Thus, most cells in the inner 
EGL that expressed P-JNK strongly were also JSAP1-positive. In addition, just superficial 
to the area showing strong P-JNK labeling, there was a thin stripe of cells that were 
positive for JSAP1, but expressed P-JNK at the low levels. Finally, calbindin 
immunolabeling was observed in cells beneath the EGL, as expected for a Purkinje cell 
marker, and some calbindin-positive cells were co-labeled by antibodies to JSAP1 and 
P-JNK (Supplementary Fig. 1). 
Together, these observations indicate that JSAP1-JNK signaling takes place at the 
appropriate time and place to play important roles in promoting GCP cell-cycle exit and 
differentiation. 
 
JSAP1 loss-of-function enhances the proliferation of cultured GCPs 
 
 To determine whether JSAP1 activity is necessary and sufficient for regulating the 
proliferation and differentiation of GCPs, we used cultured GCPs purified from the 
cerebella of P4 mice, and analyzed their expression of various markers by 
immunohistochemistry. 
 First, we characterized Ki67 and p27Kip1 expression in the primary culture system 24 
h and 72 h after plating (Fig. 3), in the presence or absence of Shh. In the absence of Shh, 
the proportion of Ki67-positive proliferating cells decreased over time (44% and 27% in 
cells cultured for 24 h and 72 h, respectively), but the percentage of cells expressing 
p27Kip1 increased (50% and 71% in cells cultured for 24 h and 72 h, respectively). 
Incubation with Shh increased the GCP proliferation significantly at 24 h (62%) and 72 h 
(39%). Concomitantly, the proportion of p27Kip1-positive cells observed was lower (29% 
at 24 h and 54% at 72 h). These results are essentially consistent with those reported 
previously (Miyazawa et al., 2000). In addition, there were very few apoptotic cells or 
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glial fibrillary acidic protein-positive glial cells in the 72-h culture (data not shown). 
 To learn whether JSAP1 functions in the control of GCP proliferation and 
differentiation, we used an RNA interference (RNAi) approach. First, we examined the 
effectiveness of an shRNA specific for JSAP1 (JSAP1-shRNA) (Fig. 4A). The 
JSAP1-shRNA stem sequence is identical to, but 2 bases shorter than, that of 
JSAP1-shRNA1, the most effective of four shRNAs reported previously (Bayarsaikhan et 
al., 2007). Transient co-expression of JSAP1-shRNA with Flag-tagged JSAP1 in human 
embryo kidney 293T (HEK293T) cells almost completely suppressed the expression of 
Flag-JSAP1, confirming the effective silencing of JSAP1 expression by JSAP1-shRNA. 
Next, GCP cultures were infected with lentiviruses expressing green fluorescent protein 
(GFP) plus either a control shRNA or JSAP1-shRNA. The JSAP1-shRNA substantially 
suppressed the expression of endogenous JSAP1 (Fig. 4B). We evaluated the effect of 
JSAP1 on GCP proliferation by counting the GFP-positive GCPs that incorporated 
bromodeoxuridine (BrdU) (Fig. 4C). The proportion of JSAP1-shRNA-infected GCPs in S 
phase increased significantly compared with that in the control shRNA-infected GCPs 
(Fig. 4D). Concomitantly, the population of p27Kip1- and NeuN-positive cells significantly 
decreased in the JSAP1-shRNA-infected GCPs (data not shown). Together, these results 
suggest that JSAP1 functions to inhibit the proliferation of GCPs and to promote their 
differentiation. 
 
Inhibition of JNK activity enhances the proliferation of cultured GCPs 
 
 We next asked whether JNK also acts as a negative regulator of GCP proliferation, 
because JSAP1 is a scaffolding protein for JNK cascades (Ito et al., 1999; Kelkar et al., 
2000). To this end, we analyzed the effect of JNK inhibition on the proliferation of 
cultured GCPs. We first tested if overexpression of a fusion protein of the JSAP1 JBD 
with GFP (GFP-JBD) would inhibit the activity of JNK in HEK293T cells (Fig. 5A). 
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HEK293T cells transiently transfected with expression plasmids for either Flag-tagged 
GFP or Flag-GFP-JBD were stimulated by UV to activate JNK. The phosphorylation of 
the transcription factor c-Jun, a bona fide substrate for JNK, was analyzed by 
immunoblotting using an anti-phospho-c-Jun-specific antibody. The phosphorylation level 
of the endogenous c-Jun was markedly reduced in cells expressing Flag-GFP-JBD 
compared with those expressing Flag-GFP, indicating that the fusion protein was an 
effective JNK inhibitor. 
Next, GCP cultures were infected with lentiviruses expressing either Flag-GFP or 
Flag-GFP-JBD, and GCP proliferation was assessed by the incorporation of BrdU by 
GFP-positive GCPs (Figs. 5B, C). The proportion of the proliferating cells among 
Flag-GFP-JBD-infected GCPs significantly increased with respect to the control 
Flag-GFP-infected GCPs, and the population of p27Kip1- and NeuN-positive cells 
significantly decreased (data not shown). Together, these observations suggest that JNK, 
like JSAP1, negatively regulates GCP proliferation and promotes GCP differentiation. 
 
JSAP1-JNK signaling promotes the cell-cycle exit and differentiation of primary cultured 
GCPs 
 
 To determine whether JSAP1 promotes the cell-cycle exit and differentiation of GCPs 
in association with JNK, we overexpressed wild-type JSAP1 or its mutant lacking the JBD 
in cultured GCPs in the presence or absence of Shh, and evaluated the effects by 
immunocytochemistry with antibodies against p27Kip1 and NeuN, and by BrdU 
incorporation (Figs. 6 and 7). 
We confirmed that the hemagglutinin (HA)-tagged wild-type and mutant JSAP1 
proteins, HA-JSAP1(WT) and HA-JSAP1(ΔJBD), respectively, were expressed at similar 
levels in transiently transfected HEK293T cells (Fig. 6A). In the absence of Shh, the 
lentivirus-mediated overexpression of HA-JSAP1(WT) led to a significant increase in the 
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proportion of p27Kip1-positive cells in the GCP cultures compared with control 
lentivirus–infected cultures (Fig. 6B). Concomitantly, a significant decrease in the 
proportion of BrdU-positive cells was detected among the HA-JSAP1(WT)-infected GCPs 
(Fig. 6C). In contrast, the respective increase and decrease in the proportions of p27Kip1- 
and BrdU-positive cells seen with the expression of HA-JSAP1 were significantly smaller 
in the JSAP1(ΔJBD)-infected GCPs (Figs. 6B, C). 
We further studied whether overexpressed HA-JSAP1(WT) could exert its effects on 
GCPs even in the presence of Shh. Although Shh treatment lowered the proportion of 
p27Kip1-positive cells and increased the proportion of BrdU-positive cells in the control 
cultures, in GCP cultures overexpressing HA-JSAP1(WT), the percentage of 
p27Kip1-positive cells increased and that of the BrdU-positive cells decreased significantly, 
compared with control lentivirus–infected GCPs (Figs. 6B, C). When HA-JSAP1(ΔJBD) 
was expressed instead of HA-JSAP1(WT), the respective increase and decrease in the 
proportions of p27Kip1- and BrdU-positive cells were significantly attenuated (Fig. 6B, C). 
We also examined the effects of overexpressed HA-JSAP1(WT) or HA-JSAP1(ΔJBD) on 
the differentiation of GCPs in culture, as measured by labeling with the anti-NeuN 
antibody. The results were very similar to those obtained with the anti-p27Kip1 antibody 
(Fig. 7). 
To confirm the effect of JSAP1 on GCP differentiation, we examined the expression 
of a subset of markers for postmitotic neuroblasts, Neurod1, Nfia, and Pax6 (Morales and 
Hatten, 2006; Schüller et al., 2006; Wang et al., 2007), by quantitative real-time reverse 
transcription polymerase chain reaction (RT-PCR) analysis (Fig. 8). We coexpressed 
HA-JSAP1(WT) or HA-JSAP1(ΔJBD) with GFP in GCP cultures, and GFP-positive cells 
were purified by fluorescence-activated cell sorting (FACS). Total RNAs were then 
prepared, and subjected to real-time RT-PCR analysis using specific primers for the 
markers. As shown in Figure 8, the expression levels of all the markers examined were 
significantly higher in cells expressing HA-JSAP1(WT) compared with those expressing 
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HA-JSAP1(ΔJBD). Furthermore, when JNK activity was measured using a luciferase 
reporter system in cultured GCPs transiently expressing HA-JSAP1(WT) (Fig. 9), the JNK 
activity was found to increase dose-dependently with the amount of the expression 
plasmid used for transfection. When HA-JSAP1(ΔJBD) was used instead of 
HA-JSAP1(WT), the increase in JNK activity was significantly less, although it was not 
entirely abrogated. 
Together, these observations strongly suggest that JSAP1 antagonizes the inhibitory 
effect of Shh on GCP differentiation, promoting GCP exit from the cell cycle and 





In the present study we analyzed the role of JSAP1, a scaffold protein for JNK 
signaling pathways, in mouse cerebellar GCPs. We propose that JSAP1 antagonizes the 
mitogenic effect of Shh on GCPs, and promotes the exit of GCPs from the cell cycle and 
their differentiation by modulating JNK activity in the developing cerebellum. The 
following lines of evidence support this proposal: both JSAP1 and P-JNK are expressed 
predominately in non-dividing GCPs in the developing cerebellum; JSAP1 knockdown or 
treatment with a JNK inhibitor enhances the proliferation and suppresses the 
differentiation of cultured GCPs; the expression of exogenous wild-type JSAP1 in cultured 
GCPs leads to increased numbers of p27Kip1- and NeuN-positive cells with a concomitant 
decrease in the proportions of BrdU-positive cells, even in the presence of saturating 
concentrations of Shh; and the expression of a subset of markers for postmitotic 
neuroblasts is increased in cultured GCPs expressing exogenous wild-type JSAP1. 
Furthermore, all of these differentiation-promoting effects on GCPs are significantly 
diminished in cells expressing a mutant JSAP1 that lacks the JBD. 
 It seems likely that JSAP1 signaling complexes receive extracellular signals through 
transmembrane proteins, because JSAP1 is, at least in part, a plasma membrane-associated 
protein (Cavalli et al. 2005; Miura et al., 2006). However, to date, the physiologically 
relevant receptors that transmit signals to JSAP1 complexes remain largely unknown. 
Wechsler-Reya and Scott (1999) and Fogarty et al. (2007) reported that bFGF blocks Shh 
signaling and promotes the differentiation of GCPs. Considering that bFGF and the 
JSAP1-JNK signaling pathway have similar effects on GCPs, JSAP1 scaffolding 
complexes seem likely to act downstream of FGF receptors in GCPs to switch the cells 
from proliferation to differentiation. In addition, extracellular matrix (ECM) glycoproteins, 
such as laminin (LN), vitronectin (VN), and proteoglycans, have been shown to regulate 
the development of GCPs (Pons et al., 2001; Rubin et al., 2002; Blaess et al., 2004). Pons 
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et al. (2001) suggested that the ECM glycoprotein VN, but not LN, acts to terminate 
Shh-mediated proliferation and induce the differentiation of GCPs in the developing 
cerebellum. Thus, it is possible that the JSAP1-JNK pathways are involved in VN-specific 
integrin receptor-mediated signaling. 
The cerebellar GCPs proliferate massively in the EGL and migrate along an inward 
radial path to the IGL. We showed here that the JSAP1 protein is expressed in cells not 
only within the EGL, but also beneath it. In addition to the calbindin-positive cells, i.e. the 
Purkinje cells, a subset of the JSAP1-positive cells found beneath the EGL is likely to 
consist of migrating GCPs. We previously reported that JSAP1 cooperates with focal 
adhesion kinase (FAK) to regulate JNK activity and cell migration in cultured cells 
(Takino et al., 2002, 2005). Hirai et al. (2002, 2006) demonstrated that dual leucine zipper 
kinase (DLK), an upstream kinase in JNK cascades, regulates axon projection and 
neuronal migration in the developing cerebral cortex. In addition, DLK is expressed in the 
developing cerebellum as well (Suenaga et al., 2006). Together, these observations suggest 
that the scaffolding protein JSAP1 may be involved in the coordinated regulation of the 
axon growth and radial migration of GCPs, by organizing the DKL-JNK pathway in 
collaboration with signaling molecules such as FAK. 
The immunohistochemical analysis in the present study showed that the expression 
profile of JNK is quite similar to that of JSAP1 in P6 mice. Furthermore, the expression 
patterns for high levels of P-JNK and for JSAP1 were largely overlapping, although 
JSAP1 was also expressed in a marginally more superficial region of the inner EGL of the 
developing cerebellum where P-JNK expression was low. Previous biochemical studies by 
our group and others have strongly suggested that JSAP1 regulates JNK cascades as a 
scaffolding factor (Ito et al., 1999; Kelkar et al., 2000). Furthermore, Byrd et al. (2001) 
established by genetics that a functional relationship exists between UNC-16, the ortholog 
of JSAP1 in C. elegans, and JNK signaling. Together, these findings suggest that the slight 
positional difference we observed for these molecules in the developing cerebellum may 
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reflect the mode of JNK activation in GCPs. That is, during the cell-cycle exit step, JNK 
bound to JSAP1 is activated as P-JNK, and the scaffold protein-mediated activation of 
JNK in turn triggers the cessation of GCP proliferation, leading to the movement of the 
post-mitotic GCPs into the premigratory zone, the inner part of EGL. This sequence of 
events would produce the immunohistochemical reaction patterns that we observed. 
In mammals, there are three Jnk genes, Jnk1, Jnk2, and Jnk3. We have recently 
shown that all the Jnk genes are expressed in developing mouse brain by in situ 
hybridization (Miura et al., 2006). Here we investigated the expression of these Jnk 
mRNAs in GCPs prepared from P4 mouse cerebellum by quantitative real-time RT-PCR 
analysis, and found that the expression level of Jnk3 was highest among the Jnk genes in 
the GCPs (Supplementary Fig. 2). In addition, our group and others previously reported 
that JNK3 showed higher binding affinity to JSAP1 than did JNK1 and JNK2 (Ito et al., 
1999; Kelkar et al., 2000). Taken together, it is likely that JSAP1-JNK3 signaling would 
be mainly responsible for the regulation of GCP differentiation in the developing 
cerebellum. However, as JNK1 and JNK2, but not p38α and extracellular signal-regulated 
kinase 2 MAPKs, could also bind to JSAP1 at least in coexpressed cultured cells (Ito et al., 
1999; Kelkar et al., 2000) and JNK1/2 proteins are likely to be expressed in GCPs, we 
cannot rule out the possibility that all the JNK isoforms are involved in regulating the exit 
of GCPs from the cell cycle and their differentiation. 
Here we found that the forced expression of wild-type JSAP1 in cultured GCPs 
increased the percentages of p27Kip1- and NeuN-positive GCPs, and the population of 
BrdU-positive GCPs decreased concomitantly, and that these effects were significantly 
less strong when a mutant JSAP1 lacking the JBD was expressed instead of the wild-type 
JSAP1. Furthermore, we monitored the JNK activity by a luciferase reporter system in 
GCPs expressing wild-type JSAP1, and found enhanced JNK activity in these cells. Again, 
when the mutant JSAP1 lacking the JBD was used instead of the wild-type JSAP1, the 
enhanced JNK activity was substantially suppressed, although not completely abolished. 
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Because JSAP1 protein forms an oligomeric complex, at least when transiently 
overexpressed (Kelkar et al., 2000; our unpublished observation), a portion of the 
exogenous JSAP1 mutant might associate with the endogenous wild-type JSAP1. The 
heteromeric JSAP1 complexes may be functionally active, as in the case for the yeast 
scaffold protein Ste5 (Inoue et al, 1997), in terms of JNK activation. Alternatively, there 
may exist one or more additional signaling pathways that regulate GCP proliferation 
and/or differentiation and are independent of the JSAP1-JNK pathways. 
The CDK inhibitor p27Kip1 participates in stopping the proliferation of neural 
progenitors (Casaccia-Bonnefil et al., 1999; Miyazawa et al., 2000; Goto et al., 2004). 
Although the mechanism by which the expression of p27Kip1 is controlled in GCPs 
remains unclear, JNK organized by the scaffold protein JSAP1 may be directly involved in 
its regulation. Recently, Kawauchi et al. (2006) demonstrated that cyclin-dependent kinase 
5 (CDK5), a proline-directed serine/threonine kinase, phosphorylates and stabilizes 
p27Kip1 in cortical neurons. Because JNK is also a proline-directed serine/threonine kinase, 
JNK may fulfill this role instead of CDK5 in GCPs. It is also possible that the JSAP1-JNK 
pathways positively regulate the expression of p27Kip1 at the transcriptional level by 
modulating the activities of transcription factors. Further investigation will be necessary to 
clarify this issue. 
An important finding of this study is that a scaffold protein for JNK cascades, JSAP1, 
inhibits the Shh-induced proliferation of cultured GCPs. The deficient down-regulation of 
proliferation in cerebellar GCPs is thought to give rise to medulloblastoma, the most 
common and aggressive brain malignancy of childhood. Di Marcotullio et al. (2004) 
identified REN (also known as KCTD11) as a putative tumor suppressor, the locus of 
which is frequently deleted in human medulloblastoma. Interestingly, REN shows an 
expression profile similar to that of JSAP1 in the EGL of the developing cerebellum, and 
furthermore, antagonizes Shh signaling in cultured GCPs (Di Marcotullio et al., 2004; 
Argenti et al., 2005). The JSAP1-JNK pathways therefore may function in the control of 
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REN expression in GCPs during cerebellar development. 
 In summary, our findings suggest that the JSAP1-JNK signaling pathways regulate 
cellular programs to switch from proliferation to differentiation in cerebellar GCPs. This 
study sheds new light on the scaffolding protein-mediated mechanisms by which specific 
signaling pathways are activated and regulated spatio-temporally to determine the cell fate 







All the experiments involving animals were conducted according to the Fundamental 
Guidelines for Proper Conduct of Animal Experiments and Related Activities in Academic 
Research Institutions under the jurisdiction of the Ministry of Education, Culture, Sports, 
Science and Technology of Japan. C57BL/6J mice were purchased from SLC (Hamamatsu, 
Japan). 
 
BrdU labeling and detection 
 
For BrdU labeling, BrdU (Sigma, St. Louis, MO) was added to cultured GCPs at a 
concentration of 10 μM, 12 h before fixation, and the GCPs were processed for 
immunocytochemistry as described below. A mouse monoclonal anti-BrdU antibody 




Mice were deeply anesthetized and perfused transcardially with 4% paraformaldehyde 
(PFA) in 0.1 M sodium phosphate buffer (PB) pH 7.4. The entire brain was removed and 
postfixed overnight at 4˚C, cryoprotected in 30% sucrose, and embedded in OTC 
compound. Sections (25-μm thick) were subjected to conventional double 
immunofluorescence by incubation for 1 h at room temperature with 2% BSA, 2% goat 
serum, and 0.4% Triton X-100 in Tris-buffered saline (TBS) pH 7.4 for blocking, followed 
by overnight incubation at 4˚C with a mixture of primary antibodies, and a 3-h incubation 
at room temperature with secondary antibodies. Primary antibodies were as follows: 
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mouse monoclonal anti-Ki67 (1:100; Novocastra Laboratories, Balliol Business Park West, 
UK), mouse monoclonal anti-p27Kip1 (1:100; BD Biosciences), mouse monoclonal 
anti-NeuN (1:300; Chemicon, Temecula, CA), rabbit polyclonal anti-JSAP1 (1 μg/ml; 
Miura et al., 2006), mouse monoclonal anti-JNK (1:100; BD Biosciences), mouse 
monoclonal anti-phospho-JNK (1:100; Santa Cruz Biotechnology, Santa Cruz), rabbit 
polyclonal anti-phospho-JNK (1:100; Cell Signaling Technology, Beverly, MA), and 
mouse monoclonal anti-calbindin D28k (calbindin) (1:1000, Sigma) antibodies. Secondary 
antibodies were goat Alexa fluor 488-conjugated anti-mouse IgG and goat Alexa fluor 
568-conjugated anti-rabbit IgG antibodies (both diluted to 1:1000; Invitrogen, Carlsbad, 
CA). TOTO-3 (Invitrogen) was used as a nuclear stain. Images were captured with a 




HEK293T cells were cultured as described previously (Bayarsaikhan et al., 2007). 
Cerebellar GCPs were prepared according to established protocols (Hatten et al., 1998) 
with minor modifications. Briefly, the cerebellum of P4 mice was removed, and the pia 
mater peeled off. Tissues were trypsinized with 0.25% trypsin and 0.1% DNase I in 
Earle’s balanced salt solution (EBSS), and then triturated gently with a fire-polished 
Pasteur pipette to obtain a suspension of single cells. The cells were passed through a 
0.22-μm filter, centrifuged, and resuspended in PBS containing 2 mM EDTA. To purify 
the GCPs, the cells were loaded onto a step gradient of 35% and 60% Percoll (GE 
Healthcare, Buckinghamshire, UK), and centrifuged at 2000 x g for 20 min at room 
temperature. The cells at the 35/60% interface were collected, washed in PBS, and 
resuspended in DMEM/F-12 (Invitrogen) containing 2% BSA. The GCPs were purified 
further by discarding cells that adhered to tissue culture dishes coated with 50 μg/ml 
poly-L-lysine (PLL; Sigma) during a 30-min incubation. The non-adhering cells were 
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collected and resuspended in DMEM/F-12 containing 2% BSA, 5 μg/ml insulin (Sigma), 
100 μg/ml apotransferrin (Invitrogen), 40 ng/ml sodium selenite (Sigma), 62 ng/ml 
progesterone (Sigma), 16 μg/ml putrescine (Sigma), 2.5 mM L-glutamine (Invitrogen), 
and 25 mM KCl, at a density of 4 x 106 cells/ml. The purified cells were plated onto 
eight-well Lab-Tec chamber slides (8 x 105 cells/well; Permanox slide; Nunc Inc., 
Naperville, IL) coated with 50 μg/ml PLL, and cultured at 37˚C in a 5% CO2 atmosphere. 
For some experiments, Shh (3 μg/ml; R&D Systems, Minneapolis, MN) and/or 
recombinant lentivirus [1 x 107 transducing units (TU)/well] was added to the culture 




Cultured GCPs were fixed with 4% PFA/PBS for 30 min at 4˚C. Immunocytochemistry 
was performed by standard protocols using blocking solution (2% BSA, 2% goat serum, 
0.4% Triton X-100 in PBS), primary antibodies, and secondary antibodies. Primary 
antibodies to Ki67, p27Kip1, NeuN, and JSAP1 were as described above, and the others 
were as follows: rabbit polyclonal anti-GFP (1:300; Chemicon); rat polyclonal anti-HA 
(1:200; Roche, Welwyn Garden City, UK). Secondary antibodies to mouse and rabbit IgG 
were as described above, and the other was goat Alexa fluor 488-conjugated anti-rat IgG 
antibody (1:1000; Invitrogen). Nuclei were stained with 2 μg/ml Hoechst 33258 
(Invitrogen). For double staining using anti-BrdU and anti-GFP or anti-HA antibodies, 
cultured GCPs were first stained with the anti-GFP or anti-HA antibodies, then refixed and 
treated with 2 N HCl in double-distilled water for 20 min at 37˚C, and then stained with 
the anti-BrdU antibody. Photographs were taken with an IX71 inverted microscope 




 The mammalian expression plasmid for Flag-tagged JSAP1, pcDNA3-Flag-JSAP1, was 
described previously (Bayarsaikhan et al., 2006). To generate an expression plasmid for a 
short hairpin RNA (shRNA) against JSAP1, the following annealed oligonucleotides were 




TTGTGACACGGG-3’. The underlined letters represent mouse JSAP1 sequences 
(GenBank accession number AB043124). As a control, an shRNA against β-galactosidase 
was made, in which the following annealed oligonucleotides were inserted into pSUPER 




AGTTTTCACGGG-3’. The underlined letters represent Escherichia coli β-galactosidase 
sequences (GenBank accession number V00296). The H1 
promoter-JSAP1/β-galactosidase-shRNA cassettes in the resultant plasmids were inserted 
into the lentiviral vector pLVTH (Addgene plasmid 12262; Addgene, Cambridge, MA), to 
generate pLVTH-JSAP1-shRNA and pLVTH-β-galactosidase-shRNA, respectively. In 
pLVTH, GFP is encoded under the control of the human elongation factor 1 alpha 
promoter, as a marker. The envelope plasmid pMD2.G, encoding vesicular stomatitis virus 
glycoprotein (VSV-G) (Addgene plasmid 12259), and the packaging plasmid psPAX2 
(Addgene plasmid 12260) were provided by Addgene. The murine stem cell virus 
(MSCV) promoter in the lentiviral vector pCL20c MSCV-GFP (Hanawa et al., 2004) was 
replaced by the cytomegalovirus (CMV) immediate-early promoter, to generate pCL20c 
CMV-GFP. Expression plasmids for HA-tagged wild-type JSAP1, HA-tagged mutant 
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JSAP1 lacking the JBD (Sato et al., 2004), Flag-tagged GFP, and Flag-tagged JBD (amino 
acid resides 201-220 of mouse JSAP1) fused to GFP were generated by replacing the GFP 
coding sequence in pCL20c CMV-GFP with the coding sequence for the respective 
construct. The resultant plasmids were designated pCL20c CMV-HA-JSAP1(WT), 
pCL20c CMV-HA-JSAP1(ΔJBD), pCL20c CMV Flag-GFP, and pCL20c 
CMV-Flag-GFP-JBD, respectively. The helper plasmids pCAGkGP1R, pCAG4RTR2, and 
pCAG-VSV-G as well as pCL20c MSCV-GFP were kindly provided by Dr. Arthur W. 
Nienhuis (St. Jude Children’s Research Hospital). 
 
Viral vector preparation 
 
VSV-G-pseudotyped human immunodeficiency virus vectors were used in this study. The 
pCL20c series of viral vectors was produced by the cotransfection of HEK293T cells with 
a mixture of four plasmids, pCAGkGP1R, pCAG4RTR2, pCAG-VSV-G, and pCL20c, 
using a calcium phosphate precipitation method as described previously (Torashima et al., 
2006a, 2006b). The pLVTH series of viral vectors was also produced, by the transient 
transfection of HEK293T cells plated in 100-mm dishes, with similar procedures: the 
plasmids used for each transfection were 15 μg pLVTH or pLVTH-JSAP1-shRNA, 11.25 
μg psPAX2, and 3.75 μg of pMD2.G. The medium, containing the viral particles, was 
harvested 64 h after the transfection. The medium samples were filtered through 0.45-μm 
membranes, centrifuged at 25,000 rpm for 90 min, resuspended in PBS (pH 7.4), and 
stored as frozen aliquots at –80˚C until use. The titers (TU/ml) of virus stocks were 




HEK293T cells were transfected with expression plasmids using a calcium phosphate 
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precipitation method. Forty-eight hours after the transfection, the cells were lysed in RIPA 
buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1% Nonidet P40, 0.1% sodium 
deoxycholate) containing Protease Inhibitor Cocktail (Sigma). Western blot analysis was 
carried out as described previously (Sato et al., 2004), using mouse monoclonal anti-Flag 
M2 (1:5000; Sigma), mouse monoclonal anti-HA (1:2000; Invivogen), mouse monoclonal 
anti-α-tubulin (1:5000; Sigma), rabbit polyclonal anti-c-Jun (1:1000; Cell Signaling 
Technology), and rabbit polyclonal anti-phospho-c-Jun (1:1000; Cell Signaling 
Technology) antibodies. Protein bands were visualized by the ECL Plus 




GCPs were prepared as described above. To examine the role of JSAP1 during GCP 
differentiation, cells (1 x 106 cells) were transfected with 500 ng pCL20c CMV-GFP alone, 
or with 500 ng of either pCL20c CMV-HA-JSAP1(WT) or pCL20c 
CMV-HA-JSAP1(ΔJBD) using the Mouse Neuron Nucleofector Kit (Amaxa Biosystems, 
Cologne, Germany). After 48 h of culture, GFP-positive GCPs were sorted by using a 
FACS (FACSAria; BD Biosciences). For the analysis of the expression of Jnk genes, 
GCPs prepared as described above were used as RNA sources. Total RNAs were extracted 
using the RNeasy Mini Kit (Qiagen, Hilden, Germany) according to the manufacturer’s 
instructions, and the RNA samples were treated with RNase-free DNase I (Promega, 
Madison, WI) to eliminate genomic DNA contamination. Real time RT-PCR was 
performed as described previously (Sato et al., 2005). The expression level of each mRNA 
was normalized with respect to that of Gapdh mRNA. The following primers were used: 
Jnk1, 5’-AAGCCTATAGGCTCAGGAGCT-3’ and 
5’-AGAACTAGTTCTCGGTAGGCG-3’; Jnk2, 5’-CCTTCTCTACCAGATGCTCTG-3’ 
and 5’-AAGTTGGTACAGGCTGTTCGC-3’; Jnk3, 
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5’-GTGGCCATTAAGAAGCTCAGC-3’ and 5’-ACTCCTCCAGTGTTTTCTGGG-3’; 
Neurod1, 5’-TCAAAGCCAACGATCGCGAGC-3’ and 
5’-GTAGTTGTAGGCGAAGCGCAG-3’; Nfia, 5’-ATGAGTCCAGGAGCAATGAGG-3’ 
and 5’-CGCCCTTGGCCTGTGTAAAAT-3’; Pax6, 
5’-TGCTTGGGAAATCCGAGACAG-3’ and 5’-GCCCATCTGTTGCTTTTCGCT-3’; 





GCPs were prepared as described above. Cells (1 x 106 cells) were cotransfected with 100 
ng pFR-Luc, 100 ng pFA-cJun, 40 ng pRL-TK Luc, and 0, 100, 200, or 500 ng of either 
pCL20c CMV-HA-JSAP1(WT) or pCL20c CMV-HA-JSAP1(ΔJBD) using the Mouse 
Neuron Nucleofector Kit (Amaxa Biosystems). pCL20c CMV-Flag-GFP was used to 
normalize the total quantity of transfected DNA (1 µg/transfection). The pFR-Luc vector 
contains a synthetic promoter with five tandem repeats of the yeast GAL4 binding sites 
and the firefly luciferase gene. The pFA-cJun vector expressing the fusion trans-activator 
protein consists of the activation domain of c-Jun fused with the DNA-binding domain of 
the yeast GAL4. The pRL-TK Luc plasmid contains the herpes simplex virus thymidine 
kinase promoter to provide moderate levels of Renilla luciferase expression. After 48 h of 
culture, the cells were lysed and assayed by using the Dual Luciferase Assay system 
(Promega). Firefly luciferase activity in the lysates was normalized using the 
corresponding internal Renilla luciferase activity, and then divided by the value for control 





Results are represented as the mean + SEM from the number of experiments indicated in 
the figure legends. Statistical differences were analyzed using the two-tailed unpaired 
Student’s t-test (Figs. 3, 4, 5, and 9), or a one-way ANOVA followed by the Tukey’s 
multiple comparison pos hoc test (Figs. 6, 7, and 8). Values of p < 0.05 were considered to 
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Figure 1. Expression of JSAP1 and marker proteins in developing mouse cerebellum. 
Sagittal sections from P6 mouse cerebella double labeled with anti-JSAP1 (red) and (in 
green) anti-Ki67 (A, B), anti-p27Kip1 (D, E), or anti-NeuN (G, H). Ki67, p27Kip1, and 
NeuN are markers for proliferating, post-mitotic, and differentiating cells, respectively. B, 
E, and H show high-magnification views of the areas indicated in A, D, and G, 
respectively. C, F, and I, show nuclei stained with TOTO-3 (blue). Cells within the EGL 
and outside the EGL were positive for JSAP1 immunolabeling. Intense labeling for JSAP1 
was detected in the inner EGL, which is a p27Kip1- and NeuN-positive, but Ki67-negative 
post-mitotic zone. By contrast, moderate or low levels JSAP1 were detected in the outer 
EGL, which was Ki67-positive, but p27Kip1- and NeuN-negative; i.e., a proliferation zone. 
outer, outer EGL; inner, inner EGL. Scale bars: 20 µm in A, D and G; 10 µm in B, C, E, F, 
H, and I. Images were captured with a confocal microscope. 
 
Figure 2. Expression of JSAP1 and JNK in developing mouse cerebellum. A-P, Sagittal 
sections from P6 mouse cerebella double-labeled with anti-JSAP1 (red) and (in green) 
anti-JNK (A-H) or anti-phosphorylated, activated JNK (P-JNK) (I-P). Lower panels (E-H 
and M-P) show high-magnification views of upper panels (A-D and I-L); the area shown 
is indicated in C for A-D and in K for I-L. Immunosignals for JNK largely overlapped 
with those for JSAP1. The expression profile of P-JNK was also similar to that of JSAP1, 
with small differences. There was little P-JNK immunoreactivity in the outer EGL. In the 
inner EGL, where P-JNK levels were high, the P-JNK-positive cells were also 
JSAP1-positive. However, just superficial to this region, there was a thin stripe of cells 
that were positive for JSAP1 that expressed only low levels of P-JNK. D, H, L, and P, 
Nuclei stained with TOTO-3 (blue). outer, outer EGL; inner, inner EGL. Scale bars: 20 µm 




Figure 3. Expression of Ki67 and p27Kip1 in cultured cerebellar GCPs. GCPs prepared 
from P4 mice were cultured with or without Shh for 24 h or 72 h, fixed, and stained with 
antibodies against Ki67 and p27Kip1. Percentage of Ki67 and p27Kip1-expressing cells 
(means + SEM from 3 experiments, *p < 0.01, Student’s t-test). A minimum of 1,000 cells 
was counted per experiment. GCPs can differentiate in this culture system, and therefore 
the proportions of Ki67- and p27Kip1-positive cells decreased and increased, respectively, 
with time. The mitogen Shh enhanced the proportion of proliferating Ki67-positive cells, 
resulting in a decreased population of cells expressing p27Kip1, a negative regulator of the 
cell cycle in GCPs. 
 
Figure 4. Knockdown of JSAP1 expression enhances the proliferation of cultured 
cerebellar GCPs. A, Representative Western blot (WB) shows the effective silencing of 
JSAP1 expression by the shRNA for JSAP1 (JSAP1-shRNA), evaluated by transient 
coexpression of the shRNA with Flag-tagged JSAP1 in HEK293T cells. A vector 
expressing β-galactosidase shRNA (control-shRNA) was used as the negative control. 
Expression of α-tubulin is shown as the loading control. B, Double immunofluorescence 
shows a much lower expression of JSAP1 in cultured P4 GCPs infected with a lentivirus 
containing the JSAP1-shRNA than in those infected with lentivirus containing the control 
shRNA. The cells were stained with antibodies to GFP (green) and JSAP1 (red) 72 h after 
infection. C, Double immunofluorescence of cultured P4 GCPs infected with lentivirus 
expressing GFP plus either control-shRNA (control-shRNA) or JSAP1-shRNA 
(JSAP1-shRNA), 72 h after infection. Before fixation, the cells were labeled with BrdU 
for 12 h. They were then stained with antibodies to GFP (green) and BrdU (red). Images 
were captured with an inverted microscope (B, C). Scale bars, 20 µm in B and C. D, The 
percentage of GFP-positive cells that were BrdU-positive in cultures infected with the 
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control lentivirus or lentivirus containing the JSAP1-shRNA (means + SEM from 3 
experiments, *p < 0.005, Student’s t-test). 
 
Figure 5. Inhibition of JNK activity enhances the proliferation of cultured cerebellar 
GCPs. A, Representative Western blot (WB) showing that a fusion protein of the JSAP1 
JNK-binding domain (JBD) with Flag-tagged GFP (Flag-GFP-JBD) acts as a JNK 
inhibitor. HEK293T cells were transiently transfected with expression vectors for 
Flag-GFP or Flag-GFP-JBD and stimulated with UV (40 J/m2) or left unstimulated. Total 
cell lysates were prepared and used for WB analysis with antibodies to phospho-c-Jun 
(P-c-Jun), c-Jun, Flag-tag, and α-tubulin. B, Double immunofluorescence of P4 GCPs 
expressing lentivirus-mediated Flag-GFP or Flag-GFP-JBD, 72 h after infection, stained 
for GFP (green) and BrdU (red). Before fixation, the cells were labeled with BrdU for 12 h. 
Images were captured with an inverted microscope. Scale bars, 20 µm.  C, Percentage of 
GFP-positive cells that were also positive for BrdU in cultures infected with lentivirus for 
Flag-GFP or Flag-GFP-JBD (means + SEM from 3 experiments, *p < 0.01, Student’s 
t-test). 
 
Figure 6. JSAP1 promotes p27Kip1 expression in cultured cerebellar GCPs and suppresses 
proliferation. A, Western blot shows similar levels of protein expression in HEK293T cells 
transfected with HA-tagged wild-type JSAP1 (HA-JSAP1(WT)) or its mutant lacking the 
JBD (HA-JSAP1(ΔJBD)). B, C, P4 GCPs cultured for 72 h with Shh (3 µg/ml) and 
infected with lentivirus expressing GFP (control), HA-JSAP1(WT), or HA-JSAP1(ΔJBD), 
and stained for GFP or HA and p27Kip1 or BrdU. Percentage of GFP- or HA-positive cells 
that were p27Kip1-positive (B) or BrdU-positive (C) (means + SEM from 3 experiments, *p 
< 0.01, one-way ANOVA). HA-JSAP1(WT) lentivirus-infected cells showed a 
significantly greater percentage of p27Kip1-positive cells than in cultures infected with the 
control lentivirus, in the absence and presence of Shh. Much less enhancement of the 
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proportion of p27Kip1-positive cells (p < 0.01 compared with HA-JSAP1(WT)) was seen in 
cultures of HA-JSAP1(ΔJBD) lentivirus-infected cells, and concomitantly, the proportion 
of BrdU-positive proliferating GCPs increased.   
 
Figure 7. JSAP1 promotes the differentiation of cultured cerebellar GCPs. P4 GCPs 
cultured for 72 h in the presence of Shh (3 μg/ml) and infected with lentiviruses for GFP 
(control), HA-JSAP1(WT), or HA-JSAP1(ΔJBD), were evaluated by double 
immunofluorescence staining for GFP or HA, and NeuN, a neural differentiation marker. 
Percentage of GFP- or HA-positive cells that were positive for NeuN (means + SEM from 
3 experiments, *p < 0.01, one-way ANOVA). Although HA-JSAP1(WT) induced a 
significant increase in GCP differentiation, HA-JSAP1(ΔJBD) had a significantly less 
strong effect on differentiation (p < 0.01) compared with HA-JSAP1(WT)) in cultures of 
lentivirus-infected cells in both the absence and presence of Shh. 
 
Figure 8. JSAP1 enhances the expression of markers for postmitotic neuroblasts in 
cultured cerebellar GCPs. GCPs prepared from P4 mice were transfected with the 
expression plasmid for GFP alone (control), or with HA-JSAP1(WT) or 
HA-JSAP1(ΔJBD), and GFP-positive cells were purified by FACS. Forty-eight hours after 
transfection, total RNAs were prepared from the cells, and subjected to real-time RT-PCR 
using the respective gene-specific primers as indicated. The expression levels of the 
mRNAs were normalized to that of Gapdh mRNA, and the quantity of each mRNA was 
determined as its ratio to the level in control cells. Values are given as means + SEM from 
3 experiments, *p < 0.05, one-way ANOVA. The expression levels of all the markers were 
significantly higher in cells expressing HA-JSAP1(WT) compared with those expressing 
HA-JSAP1(ΔJBD). 
 
Figure 9. JSAP1 overexpression in cultured cerebellar GCPs causes increased JNK 
33 
activity. GCPs prepared from P4 mice were cotransfected with the indicated amount of the 
expression plasmids for HA-JSAP1(WT) or HA-JSAP1(ΔJBD) together with firefly and 
Renilla luciferase reporter plasmids. Forty-eight hours after transfection, the cells were 
assayed for luciferase activity. The forced expression of JSAP1(WT) increased the JNK 
activity in a dose-dependent manner, and this effect was significantly suppressed when 
JSAP1(ΔJBD) was used instead of JSAP1(WT) (means + SEM from 3 experiments, *p < 
0.005, Student’s t-test). 
 
Supplementary Figure 1. Expression of JSAP1, P-JNK, and calbindin in developing 
mouse cerebellum. Sagittal sections from P6 mouse cerebella double-labeled with 
anti-calbindin (green) and (in red) anti-JSAP1 (A, B) or anti-P-JNK (D, E). B and E show 
high-magnification views of the areas indicated in A and D, respectively. C and F show 
nuclei stained with TOTO-3 (blue). Immunosignals for calbindin, a Purkinje cell marker, 
were detected beneath the EGL, but not in it, and some calbindin-positive cells were also 
positive for JSAP1 and P-JNK. calb, calbindin; outer, outer EGL; inner, inner EGL. Scale 
bars: 20 µm in A and D; 10 µm in B, C, E, and F. Images were captured with a confocal 
microscope. 
 
Supplementary Figure 2. Expression of Jnk genes in cerebellar GCPs of P4 mice. Total 
RNAs were prepared from P4 GCPs, and real-time PCR analysis was performed using the 
respective gene-specific primers as indicated. The expression levels of the mRNAs were 
normalized to that of Gapdh mRNA, and the quantity of each mRNA was determined as 
its ratio to the level of Jnk1 mRNA. Values are given as means + SEM from 3 experiments. 
The expression of Jnk3 was highest among the Jnk genes in the GCPs. 
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